Treatment Appears To Reduce Heart Attack Risk And Revascularisation In Stable Coronary Patients

Sunday, August 31, 2008 - 21:21 in Health & Medicine

Ivabradine is the first antianginal treatment shown to reduce myocardial infarction and revascularisation and to have a good tolerability profile even when used with other drugs.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net